<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Toxic plant ingestions in children: Management
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Toxic plant ingestions in children: Management
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Toxic plant ingestions in children: Management
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Alexander F Barbuto, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Michele M Burns, MD, MPH
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            James F Wiley, II, MD, MPH
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Dec 20, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H38616816">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The management of toxic plant ingestions in children will be reviewed here. Evaluation and clinical manifestations of potentially toxic plant or poisonous mushroom ingestions, the management of toxic mushroom poisoning, and contact dermatitis caused by poison ivy are discussed separately:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6507.html" rel="external">
          "Potentially toxic plant ingestions in children: Clinical manifestations and evaluation"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/16135.html" rel="external">
          "Clinical manifestations and evaluation of mushroom poisoning"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/13894.html" rel="external">
          "Management of mushroom poisoning (except amatoxin-containing mushrooms)"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/13893.html" rel="external">
          "Amatoxin-containing mushroom poisoning (eg, Amanita phalloides): Clinical manifestations, diagnosis, and treatment"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1728.html" rel="external">
          "Poison ivy (
          <i>
           Toxicodendron
          </i>
          ) dermatitis"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6622.html" rel="external">
          "Photosensitivity disorders (photodermatoses): Clinical manifestations, diagnosis, and treatment"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1787539172">
         <span class="h1">
          BACKGROUND
         </span>
         <span class="headingEndMark">
          —
         </span>
         Children are frequently exposed to potentially toxic plants, both in the home and outdoors. While these exposures rarely result in clinically significant poisoning, it is important for health care providers to be aware of the limited number of plants that have the potential to cause serious clinical effects. Most young children are asymptomatic or have minimal gastrointestinal toxicity after exploratory plant ingestions (eg, picking berries off a bush). Serious poisoning is associated with large ingestions of highly toxic plant species  (
         <a class="graphic graphic_table graphicRef69016" href="/z/d/graphic/69016.html" rel="external">
          table 1
         </a>
         ), which typically occur in the setting of suicidal ingestion, foraging mistakes, or intentional recreational use.
        </p>
        <p class="headingAnchor" id="H3216162">
         <span class="h1">
          APPROACH
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patient management and disposition after ingestion of a potentially toxic plant depends upon the plant ingested, the amount ingested, and the clinical findings:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Asymptomatic
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Nontoxic or minimally toxic plant ingestion
         </strong>
         – Patients with small ingestions of confirmed nontoxic or minimally toxic plant species  (
         <a class="graphic graphic_table graphicRef52103" href="/z/d/graphic/52103.html" rel="external">
          table 2
         </a>
         ) do not require any treatment. (See
         <a class="local">
          'Mucosal irritation'
         </a>
         below and
         <a class="local">
          'Gastroenteritis'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Unknown or potentially highly toxic plant ingestion
         </strong>
         – Patients with ingestions of unknown or potentially highly toxic plants  (
         <a class="graphic graphic_table graphicRef69016" href="/z/d/graphic/69016.html" rel="external">
          table 1
         </a>
         ), particularly consumption of large amounts, should receive medical evaluation, gastrointestinal decontamination with activated charcoal (AC) if accomplished within one to three hours, and observation for four to six hours after ingestion. In most instances, the child will remain asymptomatic and be discharged home. (See
         <a class="local">
          'Gastrointestinal decontamination'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Symptomatic
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Mucosal irritation
         </strong>
         – Patients with oral mucosal irritation after chewing or ingesting plants of the Araceae family (eg, philodendron, dieffenbachia [dumbcane]) should receive skin decontamination around the mouth, pain management, and (if able to swallow and no airway compromise) cold milk, ice cream, popsicles, or ice.
         <a class="drug drug_pediatric" data-topicid="13214" href="/z/d/drug information/13214.html" rel="external">
          Dexamethasone
         </a>
         is suggested for patients with significant lip, tongue, or other oral swelling. These patients warrant observation for signs of airway obstruction. (See
         <a class="local">
          'Mucosal irritation'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Gastroenteritis
         </strong>
         – Patients with vomiting or diarrhea that is not self-limited after ingestion of minimally toxic plants  (
         <a class="graphic graphic_table graphicRef52103" href="/z/d/graphic/52103.html" rel="external">
          table 2
         </a>
         ) may receive antiemetics (eg,
         <a class="drug drug_pediatric" data-topicid="12659" href="/z/d/drug information/12659.html" rel="external">
          ondansetron
         </a>
         ) and fluid repletion. Ondansetron should be avoided if plants known to cause prolonged QTc interval or torsades des pointes are ingested (eg
         <em>
          Aconitum
         </em>
         species [monkshood] or
         <em>
          Taxus
         </em>
         species [yew]). (See
         <a class="local">
          'Gastroenteritis'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Highly toxic plants
         </strong>
         – Patients with ingestions of highly toxic plants should receive:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Stabilization of airway, breathing, and circulation; and supportive care with expectant management determined by plant identification  (
         <a class="graphic graphic_table graphicRef69016" href="/z/d/graphic/69016.html" rel="external">
          table 1
         </a>
         ) (see
         <a class="medical medical_review" href="/z/d/html/6507.html" rel="external">
          "Potentially toxic plant ingestions in children: Clinical manifestations and evaluation", section on 'Plant identification'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Gastrointestinal decontamination with AC (see
         <a class="local">
          'Gastrointestinal decontamination'
         </a>
         below)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         For patients with severe signs of anticholinergic, cardiac glycoside, or cyanide poisoning, antidotal therapy (see
         <a class="local">
          'Anticholinergic poisoning'
         </a>
         below and
         <a class="local">
          'Cardiac glycoside poisoning'
         </a>
         below and
         <a class="local">
          'Cyanide poisoning'
         </a>
         below)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         In addition to medical management, patients who ingest highly toxic plants with intent of self-harm or for recreational purposes warrant evaluation for mental illness or drug abuse. (See
         <a class="local">
          'Supportive care'
         </a>
         below and
         <a class="local">
          'Gastrointestinal decontamination'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H38616832">
         <span class="h1">
          SUPPORTIVE CARE
         </span>
         <span class="headingEndMark">
          —
         </span>
         Treatment recommendations for children with toxic plant ingestion are primarily derived from case series and reports and are based upon physical findings. Many exploratory plant ingestions in young children ultimately involve consumption of nontoxic species that require
         <strong>
          no therapy
         </strong>
         (
         <a class="graphic graphic_table graphicRef52103" href="/z/d/graphic/52103.html" rel="external">
          table 2
         </a>
         ). Gastrointestinal irritation is the most common clinical effect associated with toxic plant ingestion in children and is typically self-limited.
        </p>
        <p>
         Clinical findings and identification of the ingested plant are helpful in determining specific management. A regional poison control center should be contacted to assist with likely plant species ingested based upon clinical findings, identification of any available plant material, knowledge of regional native flora, and treatment of specific toxic effects. Most poison control centers maintain active call lists of botanists who are knowledgeable concerning local prevalence of plant species and can assist in identification. To obtain emergency consultation with a medical toxicologist, call the United States Poison Control Network at 1-800-222-1222; contact information for poison centers around the world is provided separately. (See
         <a class="local">
          'Additional resources'
         </a>
         below.)
        </p>
        <p>
         In patients who have ingested highly toxic plants  (
         <a class="graphic graphic_table graphicRef69016" href="/z/d/graphic/69016.html" rel="external">
          table 1
         </a>
         ) or who present with signs of serious toxicity, the clinician should rapidly perform an initial assessment of clinical findings and support airway, breathing, and circulation as needed.
        </p>
        <p>
         Antidotes are often necessary in symptomatic children who have ingested plants that cause anticholinergic, cardiac glycoside, or cyanide poisoning. (See
         <a class="local">
          'Antidotes'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H38616864">
         <span class="h2">
          Mucosal irritation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Children who chew plants of the Araceae family (eg, philodendron, dieffenbachia [dumbcane]) and other plants that contain calcium oxalate raphides (intracellular sharp projections) may develop mucosal irritation and swelling. However, most young children are asymptomatic or have only mild irritation [
         <a href="#rid1">
          1
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6507.html" rel="external">
          "Potentially toxic plant ingestions in children: Clinical manifestations and evaluation", section on 'Mucosal irritation and swelling'
         </a>
         .)
        </p>
        <p>
         For symptomatic patients, treatment consists of [
         <a href="#rid2">
          2
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Wash the skin around the mouth with soap and water.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Treat pain:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Mild pain – Oral
         <a class="drug drug_pediatric" data-topicid="13371" href="/z/d/drug information/13371.html" rel="external">
          ibuprofen
         </a>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Moderate pain – Oral opioids (eg,
         <a class="drug drug_general" data-topicid="91299" href="/z/d/drug information/91299.html" rel="external">
          hydrocodone
         </a>
         ); duration of treatment should be limited to a few days
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Severe pain – Intravenous (IV) or intranasal (IN) opioids (eg, IV
         <a class="drug drug_pediatric" data-topicid="16024" href="/z/d/drug information/16024.html" rel="external">
          morphine
         </a>
         or IV/IN
         <a class="drug drug_pediatric" data-topicid="13298" href="/z/d/drug information/13298.html" rel="external">
          fentanyl
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For patients who can swallow, administer cold milk, ice cream, popsicles, or ice; some experts also recommend application of viscous
         <a class="drug drug_pediatric" data-topicid="12551" href="/z/d/drug information/12551.html" rel="external">
          lidocaine
         </a>
         (no more than 4 mg/kg total dose) [
         <a href="#rid3">
          3
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6338.html" rel="external">
          "Clinical use of topical anesthetics in children", section on 'Viscous lidocaine'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For patients with significant lip, tongue, or oral swelling, we suggest administration of
         <a class="drug drug_pediatric" data-topicid="13214" href="/z/d/drug information/13214.html" rel="external">
          dexamethasone
         </a>
         (eg, IV dexamethasone 0.25 to 0.5 mg/kg, maximum dose 10 mg). Use of dexamethasone in these patients is supported by indirect benefit of dexamethasone for treatment of infectious and traumatic causes of upper airway swelling. (See
         <a class="medical medical_review" href="/z/d/html/6004.html" rel="external">
          "Management of croup", section on 'Glucocorticoids'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/117125.html" rel="external">
          "Complications of pediatric airway management for anesthesia", section on 'Treatment of postintubation croup'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For patients with ocular exposure, perform extensive irrigation and evaluate for corneal abrasions; chemical conjunctivitis may occur. (See
         <a class="medical medical_review" href="/z/d/html/345.html" rel="external">
          "Topical chemical burns: Initial evaluation and management", section on 'Water irrigation'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6897.html" rel="external">
          "Corneal abrasions and corneal foreign bodies: Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Observe for four to six hours to assure no progressive airway obstruction. Perform endotracheal intubation in patients with severe upper airway obstruction (eg, stridor, aphonia, and/or sniffing position)  (
         <a class="graphic graphic_table graphicRef51456" href="/z/d/graphic/51456.html" rel="external">
          table 3
         </a>
         and
         <a class="graphic graphic_table graphicRef64481" href="/z/d/graphic/64481.html" rel="external">
          table 4
         </a>
         ) [
         <a href="#rid4">
          4
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6316.html" rel="external">
          "Technique of emergency endotracheal intubation in children"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H38616840">
         <span class="h2">
          Gastroenteritis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Vomiting and diarrhea may be caused by ingestion of any of the toxic plants [
         <a href="#rid2">
          2,5
         </a>
         ]. Persistent vomiting after ingestion of minimally toxic plants  (
         <a class="graphic graphic_table graphicRef52103" href="/z/d/graphic/52103.html" rel="external">
          table 2
         </a>
         ) may be safely treated with antiemetics (eg,
         <a class="drug drug_pediatric" data-topicid="12659" href="/z/d/drug information/12659.html" rel="external">
          ondansetron
         </a>
         ). However, ondansetron may precipitate or exacerbate arrhythmias and should be avoided in patients who ingest plants associated with prolonged QTc interval and torsades des pointes (eg, monkshood, false hellebore, or yew)  (
         <a class="graphic graphic_table graphicRef69016" href="/z/d/graphic/69016.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p>
         Antispasmodic agents (eg,
         <a class="drug drug_pediatric" data-topicid="12561" href="/z/d/drug information/12561.html" rel="external">
          loperamide
         </a>
         ) should be
         <strong>
          avoided
         </strong>
         in patients with diarrhea. IV fluids should be given based upon the clinical assessment of losses and evidence of volume depletion. Patients with signs of shock should receive prompt fluid resuscitation  (
         <a class="graphic graphic_algorithm graphicRef129655" href="/z/d/graphic/129655.html" rel="external">
          algorithm 1
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/6397.html" rel="external">
          "Shock in children in resource-abundant settings: Initial management"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6103.html" rel="external">
          "Treatment of hypovolemia (dehydration) in children in resource-abundant settings"
         </a>
         .)
        </p>
        <p>
         For patients with significant ingestion of plants that cause delayed gastroenteritis with systemic toxicity (eg, castor or jequirity bean [
         <em>
          Ricinus communis
         </em>
         or
         <em>
          Abrus precatorius
         </em>
         , respectively], autumn crocus [
         <em>
          Colchicum autumnale
         </em>
         ], or May apple [
         <a class="drug drug_general" data-topicid="9786" href="/z/d/drug information/9786.html" rel="external">
          Podophyllum
         </a>
         peltatum]), activated charcoal (AC) without
         <a class="drug drug_pediatric" data-topicid="12801" href="/z/d/drug information/12801.html" rel="external">
          sorbitol
         </a>
         is recommended. These patients also warrant hospital admission for observation and expectant management of severe gastroenteritis and multisystem organ failure. (See
         <a class="local">
          'Gastrointestinal decontamination'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H38616877">
         <span class="h2">
          Cardiac arrhythmias
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although rare, a variety of bradyarrhythmias and tachyarrhythmias can occur after ingestions of a number of toxic plants (eg, oleander, death camas, azalea, monkshood, yew, false hellebore)  (
         <a class="graphic graphic_table graphicRef69016" href="/z/d/graphic/69016.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/6507.html" rel="external">
          "Potentially toxic plant ingestions in children: Clinical manifestations and evaluation", section on 'Cardiac arrhythmias'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3925410">
         <span class="h3">
          Cardiac glycosides
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with hyperkalemia or life-threatening or hemodynamically unstable arrhythmia (eg, ventricular tachycardia, ventricular fibrillation, asystole, complete heart block, Mobitz II heart block, or symptomatic bradycardia) caused by cardiac glycoside-containing plants such as foxglove (
         <em>
          Digitalis purpurea
         </em>
         ), lily of the valley (
         <em>
          Convallaria majalis
         </em>
         ), or oleander (
         <em>
          Nerium oleander
         </em>
         ) warrant treatment with digoxin-specific antibody (Fab) fragments as discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/319.html" rel="external">
          "Digitalis (cardiac glycoside) poisoning", section on 'Antidotal therapy with antibody (Fab) fragments'
         </a>
         .)
        </p>
        <p>
         Higher doses of digoxin-specific Fab fragments than typically given for
         <a class="drug drug_pediatric" data-topicid="13230" href="/z/d/drug information/13230.html" rel="external">
          digoxin
         </a>
         poisoning are usually required. Quantitative digoxin or digitoxin serum levels obtained in patients poisoned with plants that contain cardiac glycosides do
         <strong>
          not
         </strong>
         correlate with clinical toxicity and should
         <strong>
          not
         </strong>
         be used to calculate the Fab fragment dose.
        </p>
        <p class="headingAnchor" id="H139001351">
         <span class="h3">
          Bradyarrhythmias
         </span>
         <span class="headingEndMark">
          —
         </span>
         Children with clinically significant bradyarrhythmias (eg, complete atrioventricular block) following ingestion of plant species not containing cardiac glycosides  (
         <a class="graphic graphic_table graphicRef69016" href="/z/d/graphic/69016.html" rel="external">
          table 1
         </a>
         ) should first be treated with
         <a class="drug drug_pediatric" data-topicid="12875" href="/z/d/drug information/12875.html" rel="external">
          atropine
         </a>
         [
         <a href="#rid6">
          6-8
         </a>
         ]. If bradycardia with hypotension persists, then the patient should receive treatment according to Pediatric Advanced Life Support (PALS) guidance for pediatric bradycardia  (
         <a class="graphic graphic_algorithm graphicRef129941" href="/z/d/graphic/129941.html" rel="external">
          algorithm 2
         </a>
         ) [
         <a href="#rid9">
          9
         </a>
         ].
        </p>
        <p>
         Based upon calcium channel blocking activity in an animal model [
         <a href="#rid10">
          10
         </a>
         ], some medical toxicologists have proposed calcium infusion as a potential treatment for bradyarrhythmias after human yew poisoning that are refractory to the above measures [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3925800">
         <span class="h3">
          Tachyarrhythmias
         </span>
         <span class="headingEndMark">
          —
         </span>
         Ventricular tachycardia or fibrillation and torsades de pointes are features of monkshood (aconitine), false hellebore, and yew toxicity  (
         <a class="graphic graphic_table graphicRef69016" href="/z/d/graphic/69016.html" rel="external">
          table 1
         </a>
         ). Ventricular arrhythmias may be initially treated with
         <a class="drug drug_pediatric" data-topicid="12587" href="/z/d/drug information/12587.html" rel="external">
          amiodarone
         </a>
         (stable patients) [
         <a href="#rid11">
          11,12
         </a>
         ]. Cardioversion (unstable patients) or defibrillation (pulseless patients) may also be performed according to PALS guidelines  (
         <a class="graphic graphic_algorithm graphicRef129942" href="/z/d/graphic/129942.html" rel="external">
          algorithm 3
         </a>
         and
         <a class="graphic graphic_algorithm graphicRef129940" href="/z/d/graphic/129940.html" rel="external">
          algorithm 4
         </a>
         ) but are frequently ineffective [
         <a href="#rid5">
          5,11,12
         </a>
         ].
        </p>
        <p>
         Case reports suggest potential benefit from the following treatments:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_pediatric" data-topicid="12795" href="/z/d/drug information/12795.html" rel="external">
          Sodium bicarbonate
         </a>
         – Monkshood, false hellebore, and yew toxins bind to sodium channels. Rapid administration of 1 to 2 mEq/kg of hypertonic sodium bicarbonate (7.5 to 8.4%) followed by a continuous infusion of approximately 1 mEq/kg per hour of isotonic sodium bicarbonate was associated with clinical improvement in an adult with large yew seed ingestion who had widening of the QRS interval and refractory ventricular tachycardia [
         <a href="#rid13">
          13
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_pediatric" data-topicid="12982" href="/z/d/drug information/12982.html" rel="external">
          Magnesium sulfate
         </a>
         <strong>
         </strong>
         – Magnesium sulfate (20 to 50 mg/kg, maximum single dose 2 g) is suggested for patients with torsades de pointes or other polymorphic ventricular arrhythmias caused by monkshood (
         <em>
          Aconitum
         </em>
         species) poisoning [
         <a href="#rid12">
          12,14
         </a>
         ]. Magnesium administration has also been associated with successful conversion of ventricular bigeminy and prolonged QTc interval to sinus rhythm in an adult with a large ingestion of monkshood (
         <em>
          Aconitum napellus
         </em>
         ) [
         <a href="#rid15">
          15
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_pediatric" data-topicid="13302" href="/z/d/drug information/13302.html" rel="external">
          Flecainide
         </a>
         <strong>
         </strong>
         – In a review of seven cases of monkshood (
         <em>
          Aconitum
         </em>
         species) poisoning in which flecainide was administered for ventricular arrhythmias, sinus rhythm was restored in six [
         <a href="#rid12">
          12
         </a>
         ]. However, multiple simultaneous treatments were given in all of these cases. Thus, the direct contribution of flecainide in the termination of the arrhythmia is unclear.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Extracorporeal membrane oxygenation (ECMO)
         </strong>
         – Case reports describe the successful use of ECMO to support the circulation of patients with refractory ventricular arrhythmias and cardiogenic shock due to
         <em>
          Taxus
         </em>
         and
         <em>
          Aconitum
         </em>
         poisoning [
         <a href="#rid12">
          12,16,17
         </a>
         ]. Although ECMO was associated with maintenance of hemodynamic stability while permitting time for toxin metabolism in these cases, this therapy is highly invasive and is usually not warranted.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H38616885">
         <span class="h2">
          Nicotine poisoning (muscarinic and/or nicotinic findings)
         </span>
         <span class="headingEndMark">
          —
         </span>
         Nicotine is found in a variety of commercial products and plants. Exposure can cause muscarinic signs (eg, vomiting, diarrhea, bronchorrhea, salivation, and/or wheezing) and nicotinic effects (eg, muscle fasciculations, paralysis, coma, and seizures). The toxicology, clinical manifestations, and management of nicotine poisoning are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/130609.html" rel="external">
          "Nicotine poisoning (e-cigarettes, tobacco products, plants, and pesticides)"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H38616848">
         <span class="h2">
          Agitation, delirium, and/or hallucinations
         </span>
         <span class="headingEndMark">
          —
         </span>
         Central nervous system excitation with hallucinations may occur after ingestion of plants that contain lysergic acid diethylamide (LSD) congeners or
         <a class="drug drug_pediatric" data-topicid="12875" href="/z/d/drug information/12875.html" rel="external">
          atropine
         </a>
         and related anticholinergic toxins. (See
         <a class="medical medical_review" href="/z/d/html/6507.html" rel="external">
          "Potentially toxic plant ingestions in children: Clinical manifestations and evaluation", section on 'Hallucinations'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6507.html" rel="external">
          "Potentially toxic plant ingestions in children: Clinical manifestations and evaluation", section on 'Anticholinergic poisoning'
         </a>
         .)
        </p>
        <p>
         Patients with these findings should initially receive benzodiazepines (eg,
         <a class="drug drug_pediatric" data-topicid="12565" href="/z/d/drug information/12565.html" rel="external">
          lorazepam
         </a>
         0.05 to 0.1 mg/kg, typical maximum single dose 2 to 4 mg) and be placed in a quiet room. Physical restraints may be necessary. (See
         <a class="medical medical_review" href="/z/d/html/317.html" rel="external">
          "Intoxication from LSD and other common hallucinogens", section on 'Agitation and dysphoria'
         </a>
         .)
        </p>
        <p>
         <a class="drug drug_pediatric" data-topicid="12703" href="/z/d/drug information/12703.html" rel="external">
          Physostigmine
         </a>
         may be appropriate for selected patients with severe anticholinergic plant poisoning. (See
         <a class="local">
          'Anticholinergic poisoning'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H3926807">
         <span class="h2">
          Hypoglycemia and encephalopathy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Children who ingest unripe ackee fruit (
         <em>
          Blighia sapida
         </em>
         ), commonly found in West Africa and the Caribbean, may develop a Reye-like syndrome with vomiting, hypoglycemia, encephalopathy, and seizures. A similar pathology has been observed in children who consume lychee [
         <a href="#rid18">
          18
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6507.html" rel="external">
          "Potentially toxic plant ingestions in children: Clinical manifestations and evaluation", section on 'Hypoglycemia and encephalopathy'
         </a>
         .)
        </p>
        <p>
         Treatment is primarily supportive with close monitoring of the serum glucose and timely treatment of hypoglycemia with dextrose  (
         <a class="graphic graphic_table graphicRef83485" href="/z/d/graphic/83485.html" rel="external">
          table 5
         </a>
         ) [
         <a href="#rid19">
          19
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H38616892">
         <span class="h2">
          Status epilepticus
         </span>
         <span class="headingEndMark">
          —
         </span>
         Ingestion of
         <em>
          Cicuta
         </em>
         species (water hemlock) or
         <em>
          Oenanthe crocata
         </em>
         (hemlock water dropwort) is associated with recurrent seizures that may not be amenable to standard anticonvulsant therapy [
         <a href="#rid2">
          2,20
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6507.html" rel="external">
          "Potentially toxic plant ingestions in children: Clinical manifestations and evaluation", section on 'Status epilepticus'
         </a>
         .)
        </p>
        <p>
         Seizures should be treated with benzodiazepines (eg,
         <a class="drug drug_pediatric" data-topicid="12565" href="/z/d/drug information/12565.html" rel="external">
          lorazepam
         </a>
         ) as first-line therapy. If seizures persist,
         <a class="drug drug_pediatric" data-topicid="12910" href="/z/d/drug information/12910.html" rel="external">
          levetiracetam
         </a>
         ,
         <a class="drug drug_pediatric" data-topicid="12873" href="/z/d/drug information/12873.html" rel="external">
          valproic acid
         </a>
         , or
         <a class="drug drug_pediatric" data-topicid="12698" href="/z/d/drug information/12698.html" rel="external">
          phenobarbital
         </a>
         is an appropriate second-line agent because
         <a class="drug drug_pediatric" data-topicid="13327" href="/z/d/drug information/13327.html" rel="external">
          fosphenytoin
         </a>
         or
         <a class="drug drug_pediatric" data-topicid="12702" href="/z/d/drug information/12702.html" rel="external">
          phenytoin
         </a>
         is less effective for the treatment of toxin-induced seizures  (
         <a class="graphic graphic_table graphicRef55368" href="/z/d/graphic/55368.html" rel="external">
          table 6
         </a>
         ). Treatment of refractory status epilepticus is summarized in the algorithm  (
         <a class="graphic graphic_algorithm graphicRef131955" href="/z/d/graphic/131955.html" rel="external">
          algorithm 5
         </a>
         ) and discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/6192.html" rel="external">
          "Management of convulsive status epilepticus in children", section on 'Refractory status epilepticus'
         </a>
         .)
        </p>
        <p>
         Patients with status epilepticus after plant poisoning should also have repeated evaluation of serum creatine kinase, urinalysis, and urine myoglobin to monitor for the development of rhabdomyolysis and myoglobinuria [
         <a href="#rid9">
          9
         </a>
         ]. The primary treatment goals consist of fluid repletion, management of hyperkalemia, and monitoring for hypocalcemia, which are similar to rhabdomyolysis from other causes and are discussed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/14036.html" rel="external">
          "Prevention and treatment of heme pigment-induced acute kidney injury (including rhabdomyolysis)"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H38616906">
         <span class="h1">
          GASTROINTESTINAL DECONTAMINATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients who are alert and acutely present for care after ingestion of a potentially highly toxic plant or ingestion of an unknown plant, we suggest administration of activated charcoal (AC). Because diarrhea often occurs after toxic plant ingestion, the use of a cathartic (eg,
         <a class="drug drug_pediatric" data-topicid="12801" href="/z/d/drug information/12801.html" rel="external">
          sorbitol
         </a>
         ) with AC should be
         <strong>
          avoided
         </strong>
         . The greatest benefit occurs if AC is given within one hour. However, AC administration more than one hour after ingestion may be appropriate in selected patients depending upon the degree of toxicity and specific plant. Consultation with a regional poison control center is advised. The efficacy of AC as a function of time from ingestion is discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/321.html" rel="external">
          "Gastrointestinal decontamination of the poisoned patient", section on 'Activated charcoal'
         </a>
         .)
        </p>
        <p>
         AC should
         <strong>
          not
         </strong>
         be given in patients who are sedated and may not be able to protect their airway unless endotracheal intubation is performed first. However, endotracheal intubation should not be performed solely for the purpose of giving AC.
        </p>
        <p>
         Children who ingest nontoxic or minimally toxic plants  (
         <a class="graphic graphic_table graphicRef52103" href="/z/d/graphic/52103.html" rel="external">
          table 2
         </a>
         ) do not require AC. Plants that are nontoxic or minimally toxic (eg, philodendron, dieffenbachia, poinsettia) do not cause serious effects that are prevented by AC. Thus, AC administration is
         <strong>
          not
         </strong>
         necessary, and the risk of aspiration, although low, may outweigh the benefits. (See
         <a class="local">
          'Mucosal irritation'
         </a>
         above and
         <a class="local">
          'Gastroenteritis'
         </a>
         above.)
        </p>
        <p>
         The recommendation for AC administration following highly toxic plant ingestion derives from indirect evidence of benefit in volunteers who ingested other substances and in animal studies, as well as from evidence of benefit following ingestions of other medications. Plant toxins, like most complex xenobiotics, bind well to AC. (See
         <a class="medical medical_review" href="/z/d/html/321.html" rel="external">
          "Gastrointestinal decontamination of the poisoned patient", section on 'Evidence of efficacy and adverse effects'
         </a>
         .)
        </p>
        <p>
         Gastric emptying with lavage has no role in the management of plant poisoning because plant matter is not effectively removed by lavage. In adults, endoscopic removal of gastric material after potential life-threatening plant poisonings has been suggested [
         <a href="#rid21">
          21
         </a>
         ]. However, its efficacy is unclear and, given the higher risk in children, should not be routinely performed. (See
         <a class="medical medical_review" href="/z/d/html/321.html" rel="external">
          "Gastrointestinal decontamination of the poisoned patient", section on 'Gastric lavage'
         </a>
         .)
        </p>
        <p>
         In addition, syrup of ipecac is no longer recommended as a means of gastrointestinal decontamination in the poisoned patient (see
         <a class="medical medical_review" href="/z/d/html/321.html" rel="external">
          "Gastrointestinal decontamination of the poisoned patient", section on 'Syrup of Ipecac'
         </a>
         ). Syrup of ipecac may cause more symptoms than no gastric emptying in children who ingest nontoxic or minimally toxic plants and should be avoided. As an example, in a poison center-based trial of 96 children who ingested fewer than six potentially toxic berries, the administration of syrup of ipecac led to significantly more vomiting, diarrhea, and sedation than observation alone [
         <a href="#rid22">
          22
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3927241">
         <span class="h1">
          ELIMINATION ENHANCEMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         In general, plant toxins are
         <strong>
          not
         </strong>
         amenable to elimination enhancement including multiple-dose activated charcoal (MDAC), plasma exchange, hemodialysis, or charcoal hemoperfusion [
         <a href="#rid2">
          2,5,9
         </a>
         ].
        </p>
        <p>
         However, the efficacy of MDAC in yellow oleander (
         <em>
          Cascabela thevetia
         </em>
         , formerly
         <em>
          Thevetia peruviana
         </em>
         ) ingestion is not clear since two randomized trials had different results. In the largest trial of 1647 patients poisoned by yellow oleander, MDAC provided no mortality benefit when compared with a single dose of activated charcoal (AC) or placebo (6.3 versus 6.8 percent, odds ratio [OR] 0.96) [
         <a href="#rid23">
          23
         </a>
         ]. This is in contrast to a smaller trial in 401 patients who ingested yellow oleander in which MDAC was associated with a significant reduction in mortality compared with single-dose AC (2.5 versus 8 percent) [
         <a href="#rid24">
          24
         </a>
         ].
        </p>
        <p>
         Plasma exchange therapy was used to treat seven children who each consumed between 5 and 12 castor beans (
         <em>
          Ricinus communis
         </em>
         ). All children survived and had improved laboratory findings and symptoms within 48 hours of plasma exchange. While encouraging, in the absence of a comparison group, no recommendation on plasma exchange can be provided [
         <a href="#rid25">
          25
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H38616914">
         <span class="h1">
          ANTIDOTES
         </span>
         <span class="headingEndMark">
          —
         </span>
         For most serious plant poisonings, supportive care is the mainstay of treatment. However, antidotal therapy may be lifesaving in selected patients with anticholinergic, cardiac glycoside, or cyanide poisoning.
        </p>
        <p class="headingAnchor" id="H38616922">
         <span class="h2">
          Anticholinergic poisoning
         </span>
         <span class="headingEndMark">
          —
         </span>
         For children and adolescents who develop anticholinergic toxicity after plant ingestion with agitated delirium, benzodiazepines are the mainstay of treatment. Selected patients may benefit from careful administration of
         <a class="drug drug_pediatric" data-topicid="12703" href="/z/d/drug information/12703.html" rel="external">
          physostigmine
         </a>
         as discussed separately. Before physostigmine is given, the patient should be placed on a cardiac monitor, and
         <a class="drug drug_pediatric" data-topicid="12875" href="/z/d/drug information/12875.html" rel="external">
          atropine
         </a>
         and resuscitative equipment should be available at the bedside. Physostigmine should
         <strong>
          not
         </strong>
         be given to patients with known or suspected cyclic antidepressant poisoning, to patients with a QRS interval that is ≥100 msec, or to patients with normal or low heart rate [
         <a href="#rid26">
          26
         </a>
         ].
        </p>
        <p>
         The suggested dose and method of administration is 0.02 mg/kg intravenously (IV; maximum single dose 0.5 mg) slowly over five minutes. If no response, may repeat every 5 to 10 minutes until improvement up to a maximum total dose of 2 mg. (See
         <a class="medical medical_review" href="/z/d/html/305.html" rel="external">
          "Anticholinergic poisoning", section on 'Antidotal therapy with physostigmine for severe toxicity'
         </a>
         .)
        </p>
        <p>
         Because
         <a class="drug drug_pediatric" data-topicid="12703" href="/z/d/drug information/12703.html" rel="external">
          physostigmine
         </a>
         is uncommonly used and unfamiliar to many clinicians, practitioners may choose to consult with a medical toxicologist or regional poison center. In the United States, the nearest available poison control center can be reached by calling 1-800-222-1222. Contact information for poison centers around the world is provided separately. (See
         <a class="local">
          'Additional resources'
         </a>
         below.)
        </p>
        <p>
         Patients who ingest plants with
         <a class="drug drug_pediatric" data-topicid="12875" href="/z/d/drug information/12875.html" rel="external">
          atropine
         </a>
         and related anticholinergic toxins (eg, jimson weed [
         <em>
          Datura stramonium
         </em>
         ]) often develop severe agitation and delirium that may not be well controlled by supportive measures such as physical restraints or benzodiazepines [
         <a href="#rid27">
          27,28
         </a>
         ]. Successful and safe use of
         <a class="drug drug_pediatric" data-topicid="12703" href="/z/d/drug information/12703.html" rel="external">
          physostigmine
         </a>
         after jimson weed poisoning has been documented in several case reports and series [
         <a href="#rid27">
          27-29
         </a>
         ]. Administration of physostigmine to such patients can result in rapid return to baseline mental status and avoid serious complications of anticholinergic poisoning including hyperthermia, tachycardia with hemodynamic instability, seizures, or rhabdomyolysis.
        </p>
        <p class="headingAnchor" id="H38616938">
         <span class="h2">
          Cardiac glycoside poisoning
         </span>
         <span class="headingEndMark">
          —
         </span>
         Multiple cardiac glycosides similar to digitalis or digitoxin are found in a number of common ornamental plants (eg, common oleander [
         <em>
          Nerium oleander
         </em>
         ], yellow oleander [
         <em>
          Cascabela thevetia
         </em>
         , formerly
         <em>
          Thevetia peruviana
         </em>
         ], foxglove [
         <em>
          Digitalis purpurea
         </em>
         ]) [
         <a href="#rid2">
          2,5,30
         </a>
         ]. Toxicity includes vomiting, diarrhea, abdominal pain, weakness, confusion, hyperkalemia, and bradyarrhythmias, especially high-grade atrioventricular block. (See
         <a class="medical medical_review" href="/z/d/html/6507.html" rel="external">
          "Potentially toxic plant ingestions in children: Clinical manifestations and evaluation", section on 'Cardiac glycosides (eg, oleander, foxglove)'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3215304">
         <span class="h3">
          Indications for digoxin-specific Fab
         </span>
         <span class="headingEndMark">
          —
         </span>
         Digoxin-specific antibody (Fab) fragments bind to naturally occurring cardiac glycosides, including those found in plants, and reverse toxicity in human poisoning [
         <a href="#rid2">
          2,5,31
         </a>
         ]. We recommend that children who ingest cardiac glycoside-containing plants  (
         <a class="graphic graphic_table graphicRef69016" href="/z/d/graphic/69016.html" rel="external">
          table 1
         </a>
         ) and develop life-threatening arrhythmias (eg, atrioventricular node and/or severe sinus node block) or serum potassium &gt;5 to 5.5 mEq/L receive digoxin-specific Fab fragments as discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/319.html" rel="external">
          "Digitalis (cardiac glycoside) poisoning", section on 'Indications and general approach'
         </a>
         .)
        </p>
        <p>
         The following evidence supports the use of digoxin-specific Fab fragments for patients with serious plant-derived cardiac glycoside poisoning:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A trial of 66 patients with yellow oleander (
         <em>
          Cascabela thevetia
         </em>
         , formerly
         <em>
          T. peruviana
         </em>
         ) poisoning found faster resolution of bradyarrhythmias and elevated potassium in patients who received digoxin-specific Fab fragments versus placebo (71 versus 16 percent at eight hours) [
         <a href="#rid32">
          32
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Case reports have also documented successful treatment of cardiotoxicity with digoxin-specific Fab fragments in patients who ingested foxglove extract, common oleander (
         <em>
          Nerium oleander
         </em>
         ), and an herbal extract containing an unknown plant-derived cardioactive steroid [
         <a href="#rid33">
          33-36
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Quantitative
         <a class="drug drug_pediatric" data-topicid="13230" href="/z/d/drug information/13230.html" rel="external">
          digoxin
         </a>
         or digitoxin serum levels obtained in patients poisoned with plants that contain cardiac glycosides do not correlate with clinical toxicity and
         <strong>
          should not
         </strong>
         be used to calculate the Fab fragment dose.
        </p>
        <p class="headingAnchor" id="H3215311">
         <span class="h3">
          Dose of digoxin-specific Fab
         </span>
         <span class="headingEndMark">
          —
         </span>
         Because binding of digoxin-specific Fab fragments to naturally occurring cardiac glycosides is less efficient than in patients with
         <a class="drug drug_pediatric" data-topicid="13230" href="/z/d/drug information/13230.html" rel="external">
          digoxin
         </a>
         or digitoxin poisoning, doses of digoxin-specific Fab fragments higher than typically given for digoxin poisoning may be necessary to achieve comparable efficacy. As an example, experts suggest that patients with common oleander (
         <em>
          Nerium oleander
         </em>
         ) or yellow oleander (
         <em>
          Cascabela thevetia
         </em>
         , formerly
         <em>
          T. peruviana
         </em>
         ) poisoning receive a starting dose of 400 mg (10 vials) of digoxin-specific Fab fragments over 20 minutes followed by 400 to 800 mg (10 to 20 vials) regardless of patient age infused over four to eight hours [
         <a href="#rid31">
          31
         </a>
         ]. These higher doses of digoxin-specific Fab fragments may be associated with a higher frequency of adverse allergic reactions (eg, hives, angioedema, or bronchospasm). Thus, the clinician should have equipment and emergency medications to treat anaphylaxis  (
         <a class="graphic graphic_table graphicRef74242" href="/z/d/graphic/74242.html" rel="external">
          table 7
         </a>
         ) immediately available during digoxin-specific Fab fragment administration.
        </p>
        <p>
         This dosing regimen for oleander poisoning is based, in part, upon a dose-finding study and subsequent trial of digoxin-specific Fab fragments in patients with yellow oleander poisoning. Findings from this study include [
         <a href="#rid32">
          32
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Ten of 12 patients who received doses of 800 to 1600 mg (20 to 40 vials) of digoxin-specific Fab fragments had conversion of arrhythmia to normal sinus rhythm or reversal of hyperkalemia compared with one of four patients who received a dose of 400 mg (10 vials).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The subsequent trial demonstrated significantly faster reversal of clinical toxicity (bradyarrhythmia, elevated potassium) among the 34 patients who received 1200 mg (30 vials) of digoxin-specific Fab fragments when compared with the 32 patients who received placebo (71 versus 16 percent at eight hours).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Adverse allergic reactions (eg, pruritus, hives, angioedema, bronchospasm) occurred in 23 percent of patients who received digoxin-specific Fab fragments during the dosing study or the trial.
        </p>
        <p>
        </p>
        <p>
         The doses of digoxin-specific Fab fragments used for oleander poisoning may not be appropriate for poisoning with other naturally occurring plant and animal cardiac glycosides, such as lily of the valley and bufotoxin. Use of digoxin-specific Fab fragments in such poisonings is empiric. (See
         <a class="medical medical_review" href="/z/d/html/328.html" rel="external">
          "Dosing regimen for digoxin-specific antibody (Fab) fragments in patients with digoxin toxicity", section on 'Cardiac glycoside poisoning other than digoxin or digitoxin'
         </a>
         .)
        </p>
        <p>
         Yellow oleander poisoning is a common method of suicide in resource-limited countries in Southeast Asia where digoxin-specific Fab fragments are not always available for treatment of serious poisoning. In resource-limited settings, experts suggest the following modification for treatment of serious cardiac glycoside poisoning [
         <a href="#rid31">
          31
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For serum potassium &gt;5.5 mEq/L, use insulin with dextrose infusion,
         <a class="drug drug_pediatric" data-topicid="12795" href="/z/d/drug information/12795.html" rel="external">
          sodium bicarbonate
         </a>
         , and potassium-binding resin. Do
         <strong>
          not
         </strong>
         give calcium. (See
         <a class="medical medical_review" href="/z/d/html/2332.html" rel="external">
          "Treatment and prevention of hyperkalemia in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Treat severe atrioventricular block with
         <a class="drug drug_pediatric" data-topicid="12875" href="/z/d/drug information/12875.html" rel="external">
          atropine
         </a>
         and, if not responsive to atropine, cardiac pacing.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Treat ventricular tachycardia with low-dose cardioversion (eg, 0.25 to 0.5 joules/kg) and ventricular fibrillation with low-dose defibrillation (eg, 2 joules/kg, maximum dose 100 joules).
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H38616930">
         <span class="h2">
          Cyanide poisoning
         </span>
         <span class="headingEndMark">
          —
         </span>
         Many fruit pits and seeds (eg, cherry, apricot, peach, plum, pear, almond, apple) contain cyanogenic glycosides such as amygdalin that are converted to hydrogen cyanide by gut bacteria after ingestion of masticated seeds or pits  (
         <a class="graphic graphic_table graphicRef69016" href="/z/d/graphic/69016.html" rel="external">
          table 1
         </a>
         ). Cyanide poisoning also complicates ingestion of amygdalin and laetrile (a chemical congener of amygdalin) sold as alternative treatments for cancer.
        </p>
        <p>
         The clinical findings of cyanide poisoning are delayed several hours after toxic ingestion of amygdalin-containing seeds or herbal preparations and include vomiting, abdominal pain, tachypnea, tachycardia, ventricular arrhythmias, confusion, coma, and seizures. Severe lactic acidosis can occur. There may be absence of cyanosis despite obvious respiratory distress. Cherry-red skin is an uncommon finding. (See
         <a class="medical medical_review" href="/z/d/html/6507.html" rel="external">
          "Potentially toxic plant ingestions in children: Clinical manifestations and evaluation", section on 'Cyanide poisoning'
         </a>
         .)
        </p>
        <p>
         Like other patients with probable cyanide poisoning, children who have ingested cyanogenic plants and have findings of cyanide poisoning warrant emergency treatment with IV
         <a class="drug drug_pediatric" data-topicid="13365" href="/z/d/drug information/13365.html" rel="external">
          hydroxocobalamin
         </a>
         (70 mg/kg, maximum dose 5 g),
         <a class="drug drug_pediatric" data-topicid="12800" href="/z/d/drug information/12800.html" rel="external">
          sodium thiosulfate
         </a>
         25% (1.65 mL/kg [412.5 mg/kg]) may also be administered to patients with extreme toxicity refractory to hydroxocobalamin. This recommendation is based upon direct evidence of benefit of this combined regimen for the treatment of cyanide poisoning (see
         <a class="medical medical_review" href="/z/d/html/299.html" rel="external">
          "Cyanide poisoning", section on 'Suspected cyanide intoxication'
         </a>
         ). Rebound toxicity 12 hours after initial treatment and requiring repeat administration of cyanide antidotes has been described in an adult patient following amygdalin ingestion [
         <a href="#rid37">
          37
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H38617045">
         <span class="h1">
          ADDITIONAL RESOURCES
         </span>
        </p>
        <p class="headingAnchor" id="H1147406604">
         <span class="h2">
          Regional poison control centers
         </span>
         <span class="headingEndMark">
          —
         </span>
         Regional poison control centers in the United States are available at all times for consultation on patients with known or suspected poisoning, and who may be critically ill, require admission, or have clinical pictures that are unclear (1-800-222-1222). In addition, some hospitals have medical toxicologists available for bedside consultation. Whenever available, these are invaluable resources to help in the diagnosis and management of ingestions or overdoses. Contact information for poison centers around the world is provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/138307.html" rel="external">
          "Society guideline links: Regional poison control centers"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H38617053">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Approach
         </strong>
         – Patient management after ingestion of a potentially toxic plant is determined by clinical findings and, when known, the plant ingested. (See
         <a class="local">
          'Approach'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Asymptomatic patients
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Nontoxic or minimally toxic plant ingestion
         </strong>
         – Patients with small ingestions of confirmed nontoxic or minimally toxic plant species  (
         <a class="graphic graphic_table graphicRef52103" href="/z/d/graphic/52103.html" rel="external">
          table 2
         </a>
         ) do not require any treatment. (See
         <a class="local">
          'Mucosal irritation'
         </a>
         above and
         <a class="local">
          'Gastroenteritis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Unknown or potentially highly toxic plant ingestion
         </strong>
         – Patients with ingestions of unknown or potentially highly toxic plants  (
         <a class="graphic graphic_table graphicRef69016" href="/z/d/graphic/69016.html" rel="external">
          table 1
         </a>
         ), particularly consumption of large amounts, should receive medical evaluation, gastrointestinal decontamination as described below, and observation for four to six hours. In most instances, the child will remain asymptomatic and be discharged home. (See
         <a class="local">
          'Gastrointestinal decontamination'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Symptomatic
         </strong>
         <strong>
          patients
         </strong>
         –
         <strong>
         </strong>
         Treatment of a child who is symptomatic after a plant ingestion consists of local or gastrointestinal decontamination, supportive care based upon specific plant toxicity, and, in selected patients, antidotal therapy:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Mucosal irritation
         </strong>
         – Initial treatment of patients with oral mucosal irritation after chewing or ingesting plants of the Araceae family (eg, philodendron, dieffenbachia [dumbcane]) consists of (see
         <a class="local">
          'Mucosal irritation'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Skin decontamination around the mouth; gastrointestinal decontamination is not warranted
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         If able to swallow and no airway compromise, cold milk, ice cream, popsicles, or ice chips
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Pain management (eg, oral
         <a class="drug drug_pediatric" data-topicid="13371" href="/z/d/drug information/13371.html" rel="external">
          ibuprofen
         </a>
         or similar nonsteroidal antiinflammatory medication)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         For patients with significant lip, tongue, or oral swelling, we suggest administration of
         <a class="drug drug_pediatric" data-topicid="13214" href="/z/d/drug information/13214.html" rel="external">
          dexamethasone
         </a>
         (eg, intravenous [IV] dexamethasone 0.25 to 0.5 mg/kg, maximum dose 10 mg) (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). These patients warrant observation for signs of airway obstruction.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Gastroenteritis
         </strong>
         – Patients with vomiting or diarrhea that is not self-limited after ingestion of minimally toxic plants  (
         <a class="graphic graphic_table graphicRef52103" href="/z/d/graphic/52103.html" rel="external">
          table 2
         </a>
         ) may receive antiemetics (eg,
         <a class="drug drug_pediatric" data-topicid="12659" href="/z/d/drug information/12659.html" rel="external">
          ondansetron
         </a>
         ) and fluid repletion as needed. Ondansetron should be avoided if plants known to cause prolonged QTc interval or torsades des pointes (eg,
         <em>
          Aconitum
         </em>
         species) are ingested. (See
         <a class="local">
          'Gastroenteritis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Highly toxic plants
         </strong>
         – Clinical findings and, when possible, identification of the ingested plant guide specific management. A regional poison control center can provide expert assistance with plant identification. (See
         <a class="local">
          'Additional resources'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Management of patients with ingestions of highly toxic plants includes stabilization of airway, breathing, and circulation; gastrointestinal decontamination; and supportive care of toxicity that varies by plant ingested  (
         <a class="graphic graphic_table graphicRef69016" href="/z/d/graphic/69016.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="local">
          'Supportive care'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Antidotes may be necessary in rare situations:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Anticholinergic toxicity
         </strong>
         – For children and adolescents who develop anticholinergic toxicity with agitated delirium after plant ingestion, benzodiazepines are the mainstay of treatment. Selected patients may benefit from careful administration of
         <a class="drug drug_pediatric" data-topicid="12703" href="/z/d/drug information/12703.html" rel="external">
          physostigmine
         </a>
         as discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/305.html" rel="external">
          "Anticholinergic poisoning", section on 'Antidotal therapy with physostigmine for severe toxicity'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Cardiac glycoside toxicity
         </strong>
         – Patients with hyperkalemia or life-threatening or hemodynamically unstable arrhythmia caused by ingestion of cardiac glycoside-containing plants warrant treatment with digoxin-specific antibody (Fab) fragments. Higher doses of digoxin-specific Fab fragments than typically given for
         <a class="drug drug_pediatric" data-topicid="13230" href="/z/d/drug information/13230.html" rel="external">
          digoxin
         </a>
         poisoning are usually required. Quantitative digoxin or digitoxin serum levels in these patients do
         <strong>
          not
         </strong>
         correlate with clinical toxicity and should
         <strong>
          not
         </strong>
         be used to calculate the Fab fragment dose. (See
         <a class="medical medical_review" href="/z/d/html/319.html" rel="external">
          "Digitalis (cardiac glycoside) poisoning", section on 'Antidotal therapy with antibody (Fab) fragments'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Cyanide toxicity
         </strong>
         – Like other patients with probable cyanide poisoning, children who have ingested cyanogenic plants and who have findings of cyanide poisoning warrant emergency treatment with
         <a class="drug drug_pediatric" data-topicid="13365" href="/z/d/drug information/13365.html" rel="external">
          hydroxocobalamin
         </a>
         ,
         <a class="drug drug_pediatric" data-topicid="12800" href="/z/d/drug information/12800.html" rel="external">
          sodium thiosulfate
         </a>
         may also be administered to patients with extreme toxicity that is refractory to hydroxocobalamin as discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/299.html" rel="external">
          "Cyanide poisoning", section on 'Suspected cyanide intoxication'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         Rebound toxicity after initial recovery is possible and may require retreatment. (See
         <a class="local">
          'Cyanide poisoning'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Gastrointestinal decontamination
         </strong>
         – Activated charcoal (AC) is not necessary after ingestion of nontoxic or minimally toxic plants. For patients who are alert and acutely present for care after confirmed ingestion of a highly toxic plant or after ingestion of an unknown plant, we suggest administration of AC without
         <a class="drug drug_pediatric" data-topicid="12801" href="/z/d/drug information/12801.html" rel="external">
          sorbitol
         </a>
         (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). Because diarrhea often occurs after toxic plant ingestion, the use of a cathartic (eg, sorbitol) with AC should be
         <strong>
          avoided
         </strong>
         . AC should
         <strong>
          not
         </strong>
         be given in patients who are sedated and may not be able to protect their airway unless endotracheal intubation is performed first. (See
         <a class="local">
          'Gastrointestinal decontamination'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Mental health evaluation
         </strong>
         – In addition to medical management, patients who ingest highly toxic plants with intent of self-harm or for recreational purposes warrant evaluation for mental illness or substance use disorder. (See
         <a class="local">
          'Supportive care'
         </a>
         above and
         <a class="local">
          'Gastrointestinal decontamination'
         </a>
         above and
         <a class="local">
          'Antidotes'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1504015551">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges Brian A Bates, MD, who contributed to earlier versions of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Mrvos R, Dean BS, Krenzelok EP. Philodendron/dieffenbachia ingestions: are they a problem? J Toxicol Clin Toxicol 1991; 29:485.
          </a>
         </li>
         <li class="breakAll">
          Palmer M, Betz JM. Plants. In: Goldfrank’s Toxicologic Emergencies, 9th ed, Nelson LS, Lewin NA, Howland MA, Hoffman RS, Goldfrank LR, Flomenbaum NE (Eds), McGraw-Hill, New York 2011. p.1537.
         </li>
         <li class="breakAll">
          Nelson LS, Balick MJ. Poisons, poisoning, syndromes, and their clinical management. In: Handbook of Poisonous and Injurious Plants, 3rd edition, Springer and The New York Botanical Garden, New York 2020. p.19.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cumpston KL, Vogel SN, Leikin JB, Erickson TB. Acute airway compromise after brief exposure to a Dieffenbachia plant. J Emerg Med 2003; 25:391.
          </a>
         </li>
         <li class="breakAll">
          Smolinske SC, Daubert GP, Spoerke DG. Poisonous plants. In: Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose, 4th ed, Shannon MW, Borron SW, Burns MJ (Eds), Saunders Elsevier, Philadelphia 2007. p.473.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gunduz A, Turedi S, Russell RM, Ayaz FA. Clinical review of grayanotoxin/mad honey poisoning past and present. Clin Toxicol (Phila) 2008; 46:437.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Festa M, Andreetto B, Ballaris MA, et al. [A case of Veratrum poisoning]. Minerva Anestesiol 1996; 62:195.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Masom CP, Kane KE, Katz KD. A 2-Year-old Girl With Bradycardia and Lethargy: Is Perseus to the Rescue? Pediatr Emerg Care 2018; 34:e60.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Froberg B, Ibrahim D, Furbee RB. Plant poisoning. Emerg Med Clin North Am 2007; 25:375.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tekol Y, Kameyama M. [Electrophysiology of the mechanisms of action of the yew toxin, taxine, on the heart]. Arzneimittelforschung 1987; 37:428.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tai YT, But PP, Young K, Lau CP. Cardiotoxicity after accidental herb-induced aconite poisoning. Lancet 1992; 340:1254.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coulson JM, Caparrotta TM, Thompson JP. The management of ventricular dysrhythmia in aconite poisoning. Clin Toxicol (Phila) 2017; 55:313.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pierog J, Kane B, Kane K, Donovan JW. Management of isolated yew berry toxicity with sodium bicarbonate: a case report in treatment efficacy. J Med Toxicol 2009; 5:84.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Adaniya H, Hayami H, Hiraoka M, Sawanobori T. Effects of magnesium on polymorphic ventricular tachycardias induced by aconitine. J Cardiovasc Pharmacol 1994; 24:721.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gottignies P, El Hor T, Tameze JK, et al. Successful treatment of monkshood (aconite napel) poisoning with magnesium sulfate. Am J Emerg Med 2009; 27:755.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Panzeri C, Bacis G, Ferri F, et al. Extracorporeal life support in a severe Taxus baccata poisoning. Clin Toxicol (Phila) 2010; 48:463.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vardon Bounes F, Tardif E, Ruiz S, et al. Suicide attempt with self-made Taxus baccata leaf capsules: survival following the application of extracorporeal membrane oxygenation for ventricular arrythmia and refractory cardiogenic shock. Clin Toxicol (Phila) 2017; 55:925.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shrivastava A, Kumar A, Thomas JD, et al. Association of acute toxic encephalopathy with litchi consumption in an outbreak in Muzaffarpur, India, 2014: a case-control study. Lancet Glob Health 2017; 5:e458.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barceloux DG. Akee fruit and Jamaican vomiting sickness (Blighia sapida Köenig). Dis Mon 2009; 55:318.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           From the Centers for Disease Control and Prevention. Water hemlock poisoning--Maine, 1992. JAMA 1994; 271:1475.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Buetler VA, Braunshausen AM, Weiler S, et al. Characteristics of emergency department presentations following ingestion of Taxus baccata (yew). Clin Toxicol (Phila) 2023; 61:104.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wax PM, Cobaugh DJ, Lawrence RA. Should home ipecac-induced emesis be routinely recommended in the management of toxic berry ingestions? Vet Hum Toxicol 1999; 41:394.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eddleston M, Juszczak E, Buckley NA, et al. Multiple-dose activated charcoal in acute self-poisoning: a randomised controlled trial. Lancet 2008; 371:579.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Silva HA, Fonseka MM, Pathmeswaran A, et al. Multiple-dose activated charcoal for treatment of yellow oleander poisoning: a single-blind, randomised, placebo-controlled trial. Lancet 2003; 361:1935.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang CF, Nie XJ, Chen GM, et al. Early plasma exchange for treating ricin toxicity in children after castor bean ingestion. J Clin Apher 2015; 30:141.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arens AM, Kearney T. Adverse Effects of Physostigmine. J Med Toxicol 2019; 15:184.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Amlo H, Haugeng KL, Wickstrøm E, et al. [Poisoning with Jimson weed. Five cases treated with physostigmine]. Tidsskr Nor Laegeforen 1997; 117:2610.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Glatstein MM, Alabdulrazzaq F, Garcia-Bournissen F, Scolnik D. Use of physostigmine for hallucinogenic plant poisoning in a teenager: case report and review of the literature. Am J Ther 2012; 19:384.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Glatstein M, Alabdulrazzaq F, Scolnik D. Belladonna Alkaloid Intoxication: The 10-Year Experience of a Large Tertiary Care Pediatric Hospital. Am J Ther 2016; 23:e74.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Krenzelok EP, Jacobsen TD, Aronis J. Is the yew really poisonous to you? J Toxicol Clin Toxicol 1998; 36:219.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bandara V, Weinstein SA, White J, Eddleston M. A review of the natural history, toxinology, diagnosis and clinical management of Nerium oleander (common oleander) and Thevetia peruviana (yellow oleander) poisoning. Toxicon 2010; 56:273.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eddleston M, Rajapakse S, Rajakanthan, et al. Anti-digoxin Fab fragments in cardiotoxicity induced by ingestion of yellow oleander: a randomised controlled trial. Lancet 2000; 355:967.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Camphausen C, Haas NA, Mattke AC. Successful treatment of oleander intoxication (cardiac glycosides) with digoxin-specific Fab antibody fragments in a 7-year-old child: case report and review of literature. Z Kardiol 2005; 94:817.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barrueto F Jr, Jortani SA, Valdes R Jr, et al. Cardioactive steroid poisoning from an herbal cleansing preparation. Ann Emerg Med 2003; 41:396.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Safadi R, Levy I, Amitai Y, Caraco Y. Beneficial effect of digoxin-specific Fab antibody fragments in oleander intoxication. Arch Intern Med 1995; 155:2121.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rich SA, Libera JM, Locke RJ. Treatment of foxglove extract poisoning with digoxin-specific Fab fragments. Ann Emerg Med 1993; 22:1904.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shively RM, Harding SA, Hoffman RS, et al. Rebound metabolic acidosis following intentional amygdalin supplement overdose. Clin Toxicol (Phila) 2020; 58:290.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 16521 Version 47.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1749055" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Philodendron/dieffenbachia ingestions: are they a problem?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1749055" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Philodendron/dieffenbachia ingestions: are they a problem?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1749055" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Philodendron/dieffenbachia ingestions: are they a problem?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14654179" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Acute airway compromise after brief exposure to a Dieffenbachia plant.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14654179" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Acute airway compromise after brief exposure to a Dieffenbachia plant.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18568799" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Clinical review of grayanotoxin/mad honey poisoning past and present.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9045097" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : [A case of Veratrum poisoning].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29494463" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : A 2-Year-old Girl With Bradycardia and Lethargy: Is Perseus to the Rescue?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17482026" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Plant poisoning.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2440454" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : [Electrophysiology of the mechanisms of action of the yew toxin, taxine, on the heart].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1359321" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Cardiotoxicity after accidental herb-induced aconite poisoning.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28421842" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : The management of ventricular dysrhythmia in aconite poisoning.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19415594" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Management of isolated yew berry toxicity with sodium bicarbonate: a case report in treatment efficacy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7532749" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Effects of magnesium on polymorphic ventricular tachycardias induced by aconitine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19751645" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Successful treatment of monkshood (aconite napel) poisoning with magnesium sulfate.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20528617" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Extracorporeal life support in a severe Taxus baccata poisoning.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28494178" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Suicide attempt with self-made Taxus baccata leaf capsules: survival following the application of extracorporeal membrane oxygenation for ventricular arrythmia and refractory cardiogenic shock.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28153514" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Association of acute toxic encephalopathy with litchi consumption in an outbreak in Muzaffarpur, India, 2014: a case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19446675" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Akee fruit and Jamaican vomiting sickness (Blighia sapida Köenig).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8176815" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : From the Centers for Disease Control and Prevention. Water hemlock poisoning--Maine, 1992.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36594830" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Characteristics of emergency department presentations following ingestion of Taxus baccata (yew).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10592952" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Should home ipecac-induced emesis be routinely recommended in the management of toxic berry ingestions?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18280328" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Multiple-dose activated charcoal in acute self-poisoning: a randomised controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12801736" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Multiple-dose activated charcoal for treatment of yellow oleander poisoning: a single-blind, randomised, placebo-controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25116073" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Early plasma exchange for treating ricin toxicity in children after castor bean ingestion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30747326" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Adverse Effects of Physostigmine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9324814" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : [Poisoning with Jimson weed. Five cases treated with physostigmine].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20861718" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Use of physostigmine for hallucinogenic plant poisoning in a teenager: case report and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24263161" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Belladonna Alkaloid Intoxication: The 10-Year Experience of a Large Tertiary Care Pediatric Hospital.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9656977" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Is the yew really poisonous to you?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20438743" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : A review of the natural history, toxinology, diagnosis and clinical management of Nerium oleander (common oleander) and Thevetia peruviana (yellow oleander) poisoning.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10768435" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Anti-digoxin Fab fragments in cardiotoxicity induced by ingestion of yellow oleander: a randomised controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16382383" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Successful treatment of oleander intoxication (cardiac glycosides) with digoxin-specific Fab antibody fragments in a 7-year-old child: case report and review of literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12605208" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Cardioactive steroid poisoning from an herbal cleansing preparation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7575073" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Beneficial effect of digoxin-specific Fab antibody fragments in oleander intoxication.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8239114" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Treatment of foxglove extract poisoning with digoxin-specific Fab fragments.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31322009" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Rebound metabolic acidosis following intentional amygdalin supplement overdose.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
